Skip to content
ppharmaranks
Menu

QBRELIS vs RETAVASE

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 8, 2026·How we rate

Possible drug interaction. QBRELIS and RETAVASE are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Rating

72/100
New

Pharmacy pays

~$0.76 /30
—

Type

RX
RX

Active ingredient

LISINOPRIL
RETEPLASE

Manufacturer

Dosage forms

Solution
Injectable

Drug class

Angiotensin Converting Enzyme Inhibitor
—

Boxed warning

Half-life

about 12 hours (the effective half-life, in adults with normal kidney function)
—

Treats

Diabetic Nephropathies, Heart Failure, Hypertension
Myocardial Infarction, Ventricular Dysfunction

Get qbrelishigher-rated option

Advertising disclosure: Some links are affiliate links. We may earn a commission at no extra cost to you. This never affects our independent ratings.

Get treatment online

Licensed online providers — consult & get prescribed if eligible.

Frequently asked questions

What is the difference between Qbrelis and Retavase?

Qbrelis contains Lisinopril, while Retavase contains Reteplase — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.